Skip to main
BCPC

Balchem (BCPC) Stock Forecast & Price Target

Balchem (BCPC) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 0%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Balchem Corp is projected to experience growth in GAAP earnings per diluted share, with expectations of $4.73 for 2025 and $5.17 for 2026, reflecting a positive trajectory in financial performance. The company anticipates continued strength in its Human Nutrition and Health segment, contributing to sequential growth and improved gross and net margins moving forward, alongside a potential debt-free status by the end of the year. Furthermore, Balchem's revenue trajectory shows promising increases, with a reported sales growth of 9.8% year-over-year and operational efficiency enhancing performance metrics.

Bears say

Balchem Corp's forecast for 2026 projects earnings of $5.10 per diluted share, a slight decline from the previous estimate of $5.17, contributing to a decrease in the price-to-earnings multiple from 39.6x to 37.9x. The company's Human Nutrition and Health and Animal Nutrition and Health segments reported revenues of $166.1 million and $56.4 million for 4Q25 and 3Q25, respectively, both of which fell short of forecasts. Risks such as slower growth in core businesses, inflationary pressures, potential product launch failures, and geopolitical disruptions create a challenging environment for Balchem, which may limit its financial performance moving forward.

Balchem (BCPC) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Balchem (BCPC) Forecast

Analysts have given Balchem (BCPC) a Buy based on their latest research and market trends.

According to 2 analysts, Balchem (BCPC) has a Buy consensus rating as of Mar 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $176, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $176, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Balchem (BCPC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.